Dorota Kruk-Kwapisz, MSc

Medical University of Warsaw, Poland

Poster(s):

• 1423 - MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)